Mitochondrial Ribosome

The mitochondrial ribosome (mitoribosome) is a membrane-tethered ribonucleoprotein complex localized within the matrix of eukaryotic mitochondria that executes translation of the hydrophobic respiratory chain polypeptides encoded by mitochondrial DNA. Descended from the 70S bacterial ribosome of the ancestral endosymbiotic Alphaproteobacteria progenitor, the mitoribosome has undergone divergent structural remodeling over 1.8 billion years of eukaryogenesis and host-organelle coevolution. Across metazoans, fungi, plants, and protists, mitoribosomes retain the conserved catalytic peptidyl transferase center (PTC) and decoding center of prokaryotic ribosomes while exhibiting extensive truncation or expansion of their ribosomal RNA (rRNA) scaffolds and the recruitment of dozens of nucleus-encoded supernumerary mitochondrial ribosomal proteins (mRPs).

In mammalian cells, the monosome sediments as a 55S particle with a molecular mass of approximately 2.71 MDa, assembled from a 28S small subunit (mt-SSU, ~1.00 MDa, containing 12S rRNA and 30 proteins) and a 39S large subunit (mt-LSU, ~1.71 MDa, containing 16S rRNA, a structural transfer RNA, and 52 proteins). Whereas the bacterial 70S ribosome exhibits a 2:1 RNA-to-protein mass ratio (~67% rRNA and ~33% protein), reductive deletions in mammalian mitochondrial rRNA coupled with the acquisition of 28 mitochondrion-specific proteins invert this stoichiometry to an approximately 1:2 RNA-to-protein mass ratio (~31% rRNA and ~69% protein). All 13 polypeptides translated by the human 55S mitoribosome are hydrophobic transmembrane core subunits of Complexes I, III, IV, and V of the oxidative phosphorylation system, including cytochrome c oxidase subunit I (MT-CO1), which are cotranslationally inserted into the inner mitochondrial membrane.

Truncation of Mammalian 12S and 16S Mitochondrial rRNAs

In the human mitochondrial genome, the two rRNA genes—MT-RNR1 (encoding the 12S rRNA of the 28S small subunit) and MT-RNR2 (encoding the 16S rRNA of the 39S large subunit)—have experienced substantial sequence deletion relative to their Escherichia coli 16S (1,542 nt) and 23S (2,904 nt) counterparts. Human 12S mt-rRNA spans 954 nucleotides, and human 16S mt-rRNA spans 1,559 nucleotides, representing a combined deletion of nearly 1,933 nucleotides (~43% reduction in total rRNA length). High-resolution single-particle cryo-electron microscopy (cryo-EM) reconstructions at 2.2–3.1 Å resolution demonstrate that these deletions eliminate peripheral surface helices across all domains while preserving the internal ribozyme core:

• 28S Small Subunit (12S mt-rRNA): Retains 32 of the 45 canonical bacterial helices, preserving the decoding A-site helix h44 (including the universally conserved monitoring adenines equivalent to bacterial A1492 and A1493) while deleting peripheral helices h6 (the spur), h8–h10, h16–h17, h21, h33, and h39.
• 39S Large Subunit (16S mt-rRNA): Retains 54 of the 101 canonical bacterial helices, maintaining Domain V (the peptidyl transferase ring and A/P-loops) and the sarcin-ricin loop (SRL, helix H95) required for GTPase translation factor activation, while losing surface-exposed helices in Domains I and III and truncating connecting segments in Domains II and IV.

Structural Compensation by Supernumerary Mitochondrial Ribosomal Proteins

To stabilize the truncated rRNA core against thermal denaturation in the matrix (~37–50 °C in respiring mitochondria), the mammalian 55S mitoribosome incorporates 82 distinct mitochondrial ribosomal proteins (30 in the 28S SSU and 52 in the 39S LSU), compared with 54 ribosomal proteins in the bacterial 70S ribosome. Of these 82 proteins, 54 are orthologous to bacterial ribosomal proteins—many of which carry large N-terminal and C-terminal polypeptide extensions that double their molecular mass—while 28 are supernumerary mRPs unique to mitochondria. All 82 human mRPs are encoded by nuclear DNA, translated in the cytosol, and imported across the mitochondrial membranes via the mitochondrial protein import and MICOS machinery.

Rather than functioning as direct 1-to-1 spatial replacements for deleted rRNA helices (the early "structural patching" hypothesis), cryo-EM structures show that most supernumerary mRPs occupy novel peripheral quaternary positions, forming an interconnected protein shell over the solvent-exposed exterior and creating specialized functional hubs such as the mRNA entrance gate (mS39/PTCD3) and the membrane-anchoring protuberance (mL45). Several supernumerary proteins were co-opted from metabolic enzyme families through gene duplication and neofunctionalization, including mS29 (death-associated protein 3, DAP3, an active GTP-binding P-loop protein forming inter-subunit bridges at the SSU head), mL44 (an RNase III-fold protein lacking catalytic residues), and the mL43/mL65 heterodimer.

In bacterial 70S, archaeal 70S, and eukaryotic cytosolic 80S ribosomes, the central protuberance (CP) of the large subunit is built around the ~120-nucleotide 5S rRNA, which bridges the peptidyl transferase center to the small subunit head via the B1a and B1b inter-subunit contacts during tRNA translocation. Mammalian, fungal, and trypanosomatid mitochondrial genomes completely lack a 5S rRNA gene. High-resolution cryo-EM maps of the human and porcine 39S mt-LSU revealed that the mammalian mitoribosome solved the loss of 5S rRNA by recruiting an endogenous mitochondrial transfer RNA transcribed directly from mitochondrial DNA as a permanent architectural scaffold within the central protuberance.

In humans (Homo sapiens), the CP incorporates mt-tRNA^Val (MT-TV, 69 nt), whereas in domestic pigs (Sus scrofa) and cattle (Bos taurus), the homologous structural pocket incorporates mt-tRNA^Phe (MT-TF, 71 nt). This structural plasticity is enabled because the CP binding pocket—formed by uL18m, bL27m, and the mitochondrion-specific proteins mL38, mL40, mL46, and mL48—recognizes the conserved L-shaped tertiary elbow and acceptor stem of the tRNA rather than anticodon-specific base identities. Remarkably, in human patient cells harboring a pathogenic mutation that destabilizes MT-TV, the human 39S large subunit undergoes an adaptive structural switch in vivo, incorporating mt-tRNA^Phe into the central protuberance to rescue mitoribosome assembly. In contrast, the yeast 74S mitoribosome (Saccharomyces cerevisiae, ~3.30 MDa) exhibits rRNA expansion segments in its 15S and 21S rRNAs rather than truncation, and constructs its central protuberance from rRNA expansion helices and supernumerary proteins without either 5S rRNA or a structural tRNA.

Mammalian mitochondrial mRNAs generated by polycistronic transcription lack both the 5′ 7-methylguanosine cap of eukaryotic cytosolic mRNAs and the Shine-Dalgarno ribosome-binding sequence of bacterial mRNAs; their coding sequences begin within 0 to 3 nucleotides of the 5′ terminus. To bind these leaderless mRNAs, the 28S small subunit employs the pentatricopeptide repeat (PPR) protein mS39 (PTCD3) at the mRNA entrance channel (uS5m and mS37), which transiently docks the LRPPRC–SLIRP mRNA chaperone complex and feeds the 5′ start codon (AUG or AUA) directly into the P-site where mitochondrial initiation factor 2 (mtIF2, containing a 37-residue insertion that functionally substitutes for bacterial IF1) and mtIF3 position N-formylmethionyl-tRNA^fMet.

Because all 13 polypeptides synthesized by the human mitoribosome are hydrophobic multi-pass inner-membrane proteins, the polypeptide exit tunnel of the 39S large subunit is remodeled for cotranslational membrane insertion:

1. Exit Tunnel Lining and mL45 Gatekeeper: Deletion of 16S rRNA Domains I and III removes the RNA walls of the lower bacterial exit tunnel, which are replaced by hydrophobic α-helices of uL22m, uL23m, uL24m, and the mitochondrion-specific protein mL45. In free, non-translating 55S mitoribosomes, the N-terminal tail of mL45 reaches inside the exit tunnel lumen, sterically blocking premature nascent chain emergence until the ribosome docks onto the inner mitochondrial membrane.
2. Tethering to the OXA1L Insertase: Upon docking at the matrix face of the inner membrane, mL45 retracts its N-terminal plug from the tunnel and binds the C-terminal matrix coiled-coil domain of the OXA1L translocase (a member of the conserved Oxa1/YidC/Alb3 membrane insertase superfamily), together with the membrane chaperone prohibitin and MBA1/MRPL45 adapters. This interaction aligns the mitoribosomal exit port directly over the five-helix transmembrane channel of OXA1L, allowing nascent α-helices of MT-CO1, MT-CYB, and MT-ND1–6 to partition laterally into the lipid bilayer as they emerge from the peptidyl transferase center without exposure to the aqueous matrix.

Although mammalian 55S mitoribosomes diverge substantially in periphery and protein composition from bacterial 70S ribosomes, the active-site rRNA pockets retain sufficient prokaryotic character that antibacterial drugs targeting bacterial translation frequently cause off-target mitochondrial toxicity in patients. Linezolid (an oxazolidinone binding the 23S PTC A-site) and chloramphenicol inhibit human 39S peptidyl transferase activity at elevated serum concentrations, causing reversible bone marrow suppression and lactic acidosis.

The most clinically established pharmacogenomic vulnerability occurs in helix h44 of the 28S decoding center encoded by MT-RNR1 (12S mt-rRNA). In bacterial 16S rRNA, nucleotides C1409 and G1491 form a canonical Watson-Crick base pair at the base of the decoding A-site pocket, creating a high-affinity binding cleft for aminoglycoside antibiotics (gentamicin, tobramycin, amikacin, streptomycin), which stabilize the flipped-out conformation of A1492/A1493 and induce lethal codon misreading. In wild-type human 12S mt-rRNA, the homologous positions (1494C and 1555A) are unpaired, widening the groove and lowering aminoglycoside binding affinity by more than 100-fold. However, in individuals carrying the maternally inherited homoplasmic or heteroplasmic variant m.1555A>G (or m.1494C>T) in MT-RNR1, a canonical 1494C:1555G (or 1494U:1555A) Watson-Crick base pair is restored across helix h44, recreating the exact bacterial aminoglycoside binding pocket inside the human 28S mitoribosome. Administration of standard therapeutic doses of aminoglycosides to carriers of m.1555A>G halts mitochondrial OXPHOS translation in cochlear hair cells of the organ of Corti, causing irreversible bilateral sensorineural hearing loss. Rapid point-of-care polymerase chain reaction genotyping of MT-RNR1 prior to neonatal gentamicin administration prevents this iatrogenic ototoxicity.

1. Amunts, A., Brown, A., Toots, J., Scheres, S. H. W., & Ramakrishnan, V. "The structure of the human mitochondrial ribosome." Science 348, 95–98 (2015). https://doi.org/10.1126/science.aaa1193
2. Greber, B. J., et al. "The complete structure of the 55S mammalian mitochondrial ribosome." Science 348, 303–308 (2015). https://doi.org/10.1126/science.aaa3872
3. Itoh, Y., et al. "Mechanism of membrane-tethered mitochondrial protein synthesis." Science 371, 846–849 (2021). https://doi.org/10.1126/science.abe0763
4. Prezant, T. R., et al. "Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness." Nature Genetics 4, 289–294 (1993). https://doi.org/10.1038/ng0793-289